Amplexa Genetics

Amplexa Genetics is a Danish biotechnology company specializing in high-quality clinical genetic testing and genomic research services. Founded in 2006 and headquartered in Odense, the company utilizes advanced Next-Generation Sequencing (NGS) and Sanger sequencing technologies to provide diagnostic solutions for complex conditions, with a particular emphasis on epilepsy and neurological disorders. Amplexa operates as both a clinical diagnostic laboratory and a Contract Research Organization (CRO), supporting pharmaceutical partners and academic institutions with genomic data analysis and clinical trial services. The laboratory is ISO 15189 accredited, ensuring that its testing procedures meet rigorous international standards for quality and reliability. Their portfolio includes comprehensive gene panels for cardiology, metabolic diseases, and hereditary cancers, facilitating personalized medicine and improved patient outcomes.